Success Metrics

Clinical Success Rate
80.0%

Based on 4 completed trials

Completion Rate
80%(4/5)
Active Trials
0(0%)
Results Posted
75%(3 trials)
Terminated
1(17%)

Phase Distribution

Ph phase_1
2
33%
Ph phase_4
2
33%
Ph phase_2
2
33%

Phase Distribution

2

Early Stage

2

Mid Stage

2

Late Stage

Phase Distribution6 total trials
Phase 1Safety & dosage
2(33.3%)
Phase 2Efficacy & side effects
2(33.3%)
Phase 4Post-market surveillance
2(33.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

80.0%

4 of 5 finished

Non-Completion Rate

20.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

6

all time

Status Distribution
Active(1)
Completed(4)
Terminated(1)

Detailed Status

Completed4
Terminated1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
0
Success Rate
80.0%
Most Advanced
Phase 4

Trials by Phase

Phase 12 (33.3%)
Phase 22 (33.3%)
Phase 42 (33.3%)

Trials by Status

terminated117%
completed467%
not_yet_recruiting117%

Recent Activity

0 active trials
Showing 5 of 6
not_yet_recruitingphase_4

Comparison of Antihistamine and Antileukotriene Add-On Therapy to Intranasal Corticosteroid in Allergic Rhinitis

NCT07532993
completedphase_4

A Pilot Study of Mirabegron and Montelukast in Cirrhotic Patients

NCT07533565
completedphase_1

Evaluation of Pharmacokinetic Interaction Between GSK3640254 and Caffeine, Metoprolol, Montelukast, Flurbiprofen, Omeprazole, Midazolam, Digoxin, and Pravastatin in Healthy Adults

NCT04425902
completedphase_2

Study of MK-1029 in Participants With Persistent Asthma That Cannot Be Controlled With Montelukast (MK-1029-015)

NCT02720081
terminatedphase_2

A Dose-Ranging Study of MK-1029 in Adults With Persistent Asthma (MK-1029-012)

NCT01656395
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT07532993Phase 4

Comparison of Antihistamine and Antileukotriene Add-On Therapy to Intranasal Corticosteroid in Allergic Rhinitis

Not Yet Recruiting
NCT07533565Phase 4

A Pilot Study of Mirabegron and Montelukast in Cirrhotic Patients

Completed
NCT04425902Phase 1

Evaluation of Pharmacokinetic Interaction Between GSK3640254 and Caffeine, Metoprolol, Montelukast, Flurbiprofen, Omeprazole, Midazolam, Digoxin, and Pravastatin in Healthy Adults

Completed
NCT02720081Phase 2

Study of MK-1029 in Participants With Persistent Asthma That Cannot Be Controlled With Montelukast (MK-1029-015)

Completed
NCT01656395Phase 2

A Dose-Ranging Study of MK-1029 in Adults With Persistent Asthma (MK-1029-012)

Terminated
NCT01943942Phase 1

Bioequivalence Study of Montelukast 10 mg Tablets

Completed

All 6 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
6